Candida vulvovaginitis classification

Jump to navigation Jump to search

Candida vulvovaginitis Microchapters


Patient Information


Historical Perspective




Differentiating Candidiasis from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


History and Symptoms

Physical Examination

Laboratory Findings

X Ray


Other Imagining Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Candida vulvovaginitis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Candida vulvovaginitis classification

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Candida vulvovaginitis classification

CDC on Candida vulvovaginitis classification

Candida vulvovaginitis classification in the news

Blogs on Candida vulvovaginitis classification

Directions to Hospitals Treating Candidiasis

Risk calculators and risk factors for Candida vulvovaginitis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2], Aravind Kuchkuntla, M.B.B.S[3]


Candida vulvovaginitis can be classified based on the duration, as well as the strain of Candida causing the infection.


Candida vulvovaginitis can be classified based on the duration of the infection and based on the strain of Candida causing the infection.


Candida vulvovaginitis can be divided based on the duration and number of episodes of the infection into:[1][2][3][4]

  • Acute, uncomplicated: these are usually sporadic cases of Candida vulvovaginitis, which respond to topical antifungal therapy and have a high cure rate.
  • Acute, complicated: symptoms are more severe than uncomplicated infections and typically require a combination of oral and topical anti-fungal treatment.
  • Recurrent Vulvovaginal Candidiasis (RVVC): defined as 4 or more episodes of Candida vulvovaginitis per year, usually caused by the same strain of Candida. Treatment also requires a combination of oral and topical antifungal agents.
  • According to 2015, Treatment of STD guidelines - Candida vulvovaginitis can be classified into uncomplicated and complicated based on the following features:[5]
Uncomplicated Candida Vulvovaginitis Complicated Candida Vulvovaginitis
  • Sporadic or infrequent VVC
  • Mild-to-moderate VVC
  • Likely to be Candida albicans
  • Non-immunocompromised women


  1. Eckert LO (2006). "Clinical practice. Acute vulvovaginitis". N. Engl. J. Med. 355 (12): 1244–52. doi:10.1056/NEJMcp053720. PMID 16990387.
  2. Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR (1998). "Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations". Am. J. Obstet. Gynecol. 178 (2): 203–11. PMID 9500475.
  3. Sobel JD (2007). "Vulvovaginal candidosis". Lancet. 369 (9577): 1961–71. doi:10.1016/S0140-6736(07)60917-9. PMID 17560449.
  4. Vazquez JA, Sobel JD, Demitriou R, Vaishampayan J, Lynch M, Zervos MJ (1994). "Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis". J. Infect. Dis. 170 (6): 1566–9. PMID 7995997.
  5. Workowski KA (2015). "Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines". Clin Infect Dis. 61 Suppl 8: S759–62. doi:10.1093/cid/civ771. PMID 26602614.